List of Tables
Table 1. Global Pediatric Diabetes Therapeutic Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pediatric Diabetes Therapeutic Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pediatric Diabetes Therapeutic Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pediatric Diabetes Therapeutic Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pediatric Diabetes Therapeutic Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pediatric Diabetes Therapeutic Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pediatric Diabetes Therapeutic Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pediatric Diabetes Therapeutic, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pediatric Diabetes Therapeutic, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pediatric Diabetes Therapeutic, Product Types and Applications
Table 12. Global Key Manufacturers of Pediatric Diabetes Therapeutic, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Diabetes Therapeutic Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pediatric Diabetes Therapeutic Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pediatric Diabetes Therapeutic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pediatric Diabetes Therapeutic Sales by Region (K Units), 2021–2026
Table 18. Global Pediatric Diabetes Therapeutic Sales Market Share by Region (2021–2026)
Table 19. Global Pediatric Diabetes Therapeutic Sales by Region (K Units), 2027–2032
Table 20. Global Pediatric Diabetes Therapeutic Sales Market Share by Region (2027–2032)
Table 21. Global Pediatric Diabetes Therapeutic Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pediatric Diabetes Therapeutic Revenue Market Share by Region (2021–2026)
Table 23. Global Pediatric Diabetes Therapeutic Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pediatric Diabetes Therapeutic Revenue Market Share by Region (2027–2032)
Table 25. North America Pediatric Diabetes Therapeutic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pediatric Diabetes Therapeutic Sales by Country (K Units), 2021–2026
Table 27. North America Pediatric Diabetes Therapeutic Sales by Country (K Units), 2027–2032
Table 28. North America Pediatric Diabetes Therapeutic Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pediatric Diabetes Therapeutic Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pediatric Diabetes Therapeutic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pediatric Diabetes Therapeutic Sales by Country (K Units), 2021–2026
Table 32. Europe Pediatric Diabetes Therapeutic Sales by Country (K Units), 2027–2032
Table 33. Europe Pediatric Diabetes Therapeutic Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pediatric Diabetes Therapeutic Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pediatric Diabetes Therapeutic Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pediatric Diabetes Therapeutic Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pediatric Diabetes Therapeutic Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pediatric Diabetes Therapeutic Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pediatric Diabetes Therapeutic Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pediatric Diabetes Therapeutic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pediatric Diabetes Therapeutic Sales by Country (K Units), 2021–2026
Table 42. Latin America Pediatric Diabetes Therapeutic Sales by Country (K Units), 2027–2032
Table 43. Latin America Pediatric Diabetes Therapeutic Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pediatric Diabetes Therapeutic Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pediatric Diabetes Therapeutic Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pediatric Diabetes Therapeutic Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pediatric Diabetes Therapeutic Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pediatric Diabetes Therapeutic Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pediatric Diabetes Therapeutic Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pediatric Diabetes Therapeutic Sales (K Units) by Type (2021–2026)
Table 51. Global Pediatric Diabetes Therapeutic Sales (K Units) by Type (2027–2032)
Table 52. Global Pediatric Diabetes Therapeutic Sales Market Share by Type (2021–2026)
Table 53. Global Pediatric Diabetes Therapeutic Sales Market Share by Type (2027–2032)
Table 54. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pediatric Diabetes Therapeutic Revenue Market Share by Type (2021–2026)
Table 57. Global Pediatric Diabetes Therapeutic Revenue Market Share by Type (2027–2032)
Table 58. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pediatric Diabetes Therapeutic Sales (K Units) by Application (2021–2026)
Table 61. Global Pediatric Diabetes Therapeutic Sales (K Units) by Application (2027–2032)
Table 62. Global Pediatric Diabetes Therapeutic Sales Market Share by Application (2021–2026)
Table 63. Global Pediatric Diabetes Therapeutic Sales Market Share by Application (2027–2032)
Table 64. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pediatric Diabetes Therapeutic Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pediatric Diabetes Therapeutic Revenue Market Share by Application (2021–2026)
Table 67. Global Pediatric Diabetes Therapeutic Revenue Market Share by Application (2027–2032)
Table 68. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Application (2027–2032)
Table 70. Boehringer Ingelheim International GmbH Company Information
Table 71. Boehringer Ingelheim International GmbH Description and Business Overview
Table 72. Boehringer Ingelheim International GmbH Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Boehringer Ingelheim International GmbH Pediatric Diabetes Therapeutic Product
Table 74. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 75. Eli Lilly and Company Company Information
Table 76. Eli Lilly and Company Description and Business Overview
Table 77. Eli Lilly and Company Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eli Lilly and Company Pediatric Diabetes Therapeutic Product
Table 79. Eli Lilly and Company Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Sanofi Pediatric Diabetes Therapeutic Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Vertex Pharmaceuticals incorporated Company Information
Table 86. Vertex Pharmaceuticals incorporated Description and Business Overview
Table 87. Vertex Pharmaceuticals incorporated Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Vertex Pharmaceuticals incorporated Pediatric Diabetes Therapeutic Product
Table 89. Vertex Pharmaceuticals incorporated Recent Developments/Updates
Table 90. Novo Nordisk A/S Company Information
Table 91. Novo Nordisk A/S Description and Business Overview
Table 92. Novo Nordisk A/S Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Novo Nordisk A/S Pediatric Diabetes Therapeutic Product
Table 94. Novo Nordisk A/S Recent Developments/Updates
Table 95. AstraZeneca Company Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. AstraZeneca Pediatric Diabetes Therapeutic Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. MannKind Corporation Company Information
Table 101. MannKind Corporation Description and Business Overview
Table 102. MannKind Corporation Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. MannKind Corporation Pediatric Diabetes Therapeutic Product
Table 104. MannKind Corporation Recent Developments/Updates
Table 105. Xeris Pharmaceuticals Company Information
Table 106. Xeris Pharmaceuticals Description and Business Overview
Table 107. Xeris Pharmaceuticals Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Xeris Pharmaceuticals Pediatric Diabetes Therapeutic Product
Table 109. Xeris Pharmaceuticals Recent Developments/Updates
Table 110. Amphastar Pharmaceuticals, Inc. Company Information
Table 111. Amphastar Pharmaceuticals, Inc. Description and Business Overview
Table 112. Amphastar Pharmaceuticals, Inc. Pediatric Diabetes Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Amphastar Pharmaceuticals, Inc. Pediatric Diabetes Therapeutic Product
Table 114. Amphastar Pharmaceuticals, Inc. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Pediatric Diabetes Therapeutic Distributors List
Table 118. Pediatric Diabetes Therapeutic Customers List
Table 119. Pediatric Diabetes Therapeutic Market Trends
Table 120. Pediatric Diabetes Therapeutic Market Drivers
Table 121. Pediatric Diabetes Therapeutic Market Challenges
Table 122. Pediatric Diabetes Therapeutic Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pediatric Diabetes Therapeutic
Figure 2. Global Pediatric Diabetes Therapeutic Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pediatric Diabetes Therapeutic Market Share by Type: 2025 & 2032
Figure 4. Type 1 Product Picture
Figure 5. Type 2 Product Picture
Figure 6. Global Pediatric Diabetes Therapeutic Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Pediatric Diabetes Therapeutic Market Share by Application: 2025 & 2032
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Others
Figure 11. Global Pediatric Diabetes Therapeutic Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Pediatric Diabetes Therapeutic Market Size (US$ Million), 2021–2032
Figure 13. Global Pediatric Diabetes Therapeutic Sales (K Units), 2021–2032
Figure 14. Global Pediatric Diabetes Therapeutic Average Price (US$/Unit), 2021–2032
Figure 15. Pediatric Diabetes Therapeutic Report Years Considered
Figure 16. Pediatric Diabetes Therapeutic Sales Share by Manufacturers in 2025
Figure 17. Global Pediatric Diabetes Therapeutic Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Pediatric Diabetes Therapeutic Players: Market Share by Revenue in Pediatric Diabetes Therapeutic in 2025
Figure 19. Pediatric Diabetes Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Pediatric Diabetes Therapeutic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Pediatric Diabetes Therapeutic Sales Market Share by Country (2021–2032)
Figure 22. North America Pediatric Diabetes Therapeutic Revenue Market Share by Country (2021–2032)
Figure 23. United States Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Pediatric Diabetes Therapeutic Sales Market Share by Country (2021–2032)
Figure 26. Europe Pediatric Diabetes Therapeutic Revenue Market Share by Country (2021–2032)
Figure 27. Germany Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Pediatric Diabetes Therapeutic Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Pediatric Diabetes Therapeutic Revenue Market Share by Region (2021–2032)
Figure 34. China Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Pediatric Diabetes Therapeutic Sales Market Share by Country (2021–2032)
Figure 42. Latin America Pediatric Diabetes Therapeutic Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Pediatric Diabetes Therapeutic Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Pediatric Diabetes Therapeutic Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Pediatric Diabetes Therapeutic Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Pediatric Diabetes Therapeutic by Type (2021–2032)
Figure 53. Global Revenue Market Share of Pediatric Diabetes Therapeutic by Type (2021–2032)
Figure 54. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Pediatric Diabetes Therapeutic by Application (2021–2032)
Figure 56. Global Revenue Market Share of Pediatric Diabetes Therapeutic by Application (2021–2032)
Figure 57. Global Pediatric Diabetes Therapeutic Price (US$/Unit) by Application (2021–2032)
Figure 58. Pediatric Diabetes Therapeutic Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
